Goldman Sachs’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243M | Buy |
|
|||||
|
2025
Q1 | $106M | Sell |
|
|||||
|
2024
Q4 | $198M | Buy |
|
|||||
|
2024
Q3 | $199M | Buy |
|
|||||
|
2024
Q2 | $132M | Buy |
|
|||||
|
2024
Q1 | $122M | Sell |
|
|||||
|
2023
Q4 | $114M | Sell |
|
|||||
|
2023
Q3 | $132M | Buy |
|
|||||
|
2023
Q2 | $87.9M | Sell |
|
|||||
|
2023
Q1 | $124M | Sell |
|
|||||
|
2022
Q4 | $144M | Sell |
|
|||||
|
2022
Q3 | $141M | Buy |
|
|||||
|
2022
Q2 | $27.6M | Buy |
|
|||||
|
2022
Q1 | $11.7M | Sell |
|
|||||
|
2021
Q4 | $11.3M | Buy |
|
|||||
|
2021
Q3 | $10.7M | Hold |
|
|||||
|
2021
Q2 | $10.7M | Sell |
|
|||||
|
2021
Q1 | $99.9M | Buy |
|
|||||
|
2020
Q4 | $14.6M | Hold |
|
|||||
|
2020
Q3 | $13.7M | Sell |
|
|||||
|
2020
Q2 | $16.5M | Hold |
|
|||||
|
2020
Q1 | $14.4M | Sell |
|
|||||
|
2019
Q4 | $22.1M | Sell |
|
|||||
|
2019
Q3 | $20.7M | Buy |
|
|||||
|
2019
Q2 | $9.62M | Sell |
|
|||||
|
2019
Q1 | $27.3M | Sell |
|
|||||
|
2018
Q4 | $38.4M | Sell |
|
|||||
|
2018
Q3 | $51.5M | Sell |
|
|||||
|
2018
Q2 | $47.7M | Buy |
|
|||||
|
2018
Q1 | $37M | Buy |
|
|||||
|
2017
Q4 | $14.8M | Sell |
|
|||||
|
2017
Q3 | $20.3M | Buy |
|
|||||
|
2017
Q2 | $20.7M | Sell |
|
|||||
|
2017
Q1 | $41.4M | Buy |
|
|||||
|
2016
Q4 | $28.9M | Sell |
|
|||||
|
2016
Q3 | $103M | Buy |
|
|||||
|
2016
Q2 | $88.8M | Sell |
|
|||||
|
2016
Q1 | $87.4M | Buy |
|
|||||
|
2015
Q4 | $98.3M | Buy |
|
|||||
|
2015
Q3 | $72.2M | Buy |
|
|||||
|
2015
Q2 | $81M | Buy |
|
|||||
|
2015
Q1 | $31.8M | Buy |
|
|||||
|
2014
Q4 | $23.5M | Sell |
|
|||||
|
2014
Q3 | $41.8M | Buy |
|
|||||
|
2014
Q2 | $15.8M | Buy |
|
|||||
|
2014
Q1 | $3.13M | Sell |
|
|||||
|
2013
Q4 | $3.46M | Buy |
|
|||||
|
2013
Q3 | $3.12M | Sell |
|
|||||
|
2013
Q2 | $3.02M | Buy |
|